Published in Ann Rheum Dis on February 01, 1991
Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria. Infect Immun (2000) 1.09
Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis (1997) 0.89
Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling. J Clin Invest (2012) 0.84
Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters. Rheumatol Int (2003) 0.79
IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis. Ann Rheum Dis (1995) 0.79
HLA-B27 and bacteria. Clin Rheumatol (1996) 0.77
Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease. Ann Rheum Dis (1978) 5.85
Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. J Infect Dis (1980) 2.45
Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut (1986) 2.10
Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum (1988) 1.35
Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol (1985) 1.29
Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients. Ann Rheum Dis (1987) 1.29
Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies. J Infect Dis (1989) 1.25
HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis. J Rheumatol (1985) 1.23
Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis. Ann Rheum Dis (1987) 1.22
Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease. Acta Chir Scand (1983) 1.14
Causes of arthritis. Lancet (1988) 1.08
Intestinal permeability in healthy and allergic children before and after sodium-cromoglycate treatment assessed with different-sized polyethyleneglycols (PEG 400 and PEG 1000). Clin Allergy (1984) 1.01
Intestinal permeability to polyethyleneglycol 600 in Crohn's disease. Peroperative determination in a defined segment of the small intestine. Gut (1988) 0.98
Avidity of anti-Yersinia antibodies in yersiniosis patients with and without Yersinia-triggered reactive arthritis. Arthritis Rheum (1987) 0.97
Comparison of faecal florae in patients with rheumatoid arthritis and controls. Br J Rheumatol (1987) 0.95
Acute yersinia infections in man increase intestinal permeability for low-molecular weight polyethylene glycols (PEG 400). Scand J Infect Dis (1986) 0.87
Gastrointestinal permeability in atopic and non-atopic mothers, assessed with different-sized polyethyleneglycols (PEG 400 and PEG 1000). Clin Allergy (1985) 0.86
Is the gut intrinsically abnormal in rheumatoid arthritis? Ann Rheum Dis (1988) 0.81
Gastrointestinal permeability in children with cow's milk allergy: effect of milk challenge and sodium cromoglycate as assessed with polyethyleneglycols (PEG 400 and PEG 1000). Clin Allergy (1986) 0.80
Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J (1994) 6.37
Quantitation of membrane receptor distributions by image correlation spectroscopy: concept and application. Biophys J (1993) 4.88
Modulation of virulence factor expression by pathogen target cell contact. Science (1996) 3.99
Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med (1989) 3.68
Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet (1990) 3.55
Solid-phase radioimmunoassay of rubella virus immunoglobulin G and immunoglobulin M antibodies. J Clin Microbiol (1976) 2.94
Plasmids in Yersinia enterocolitica serotypes O:3 and O:9: correlation with epithelial cell adherence in vitro. Infect Immun (1981) 2.85
The direction of membrane lipid flow in locomoting polymorphonuclear leukocytes. Science (1990) 2.58
Hospital outbreak of Yersinia enterocolitica infection. Lancet (1973) 2.56
Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. J Infect Dis (1980) 2.45
Yersiniosis as an internal disease. Ann Intern Med (1974) 2.35
Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis. Lancet (1993) 2.22
Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects. Immunol Rev (1985) 2.22
Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia-triggered reactive arthritis. Arthritis Rheum (1991) 2.18
An outbreak of Yersinia pseudotuberculosis infection. J Infect Dis (1984) 2.14
Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells. Infect Immun (1995) 2.02
The tendency of smooth and rough Salmonella typhimurium bacteria and lipopolysaccharide to hydrophobic and ionic interaction, as studied in aqueous polymer two-phase systems. Acta Pathol Microbiol Scand B (1977) 1.99
Solid-phase radioimmunoassay of rubella virus immunoglobulin M antibodies: comparison with sucrose density gradient centrifugation test. J Clin Microbiol (1977) 1.96
Measurement of immunoglobulin M (IgM), IgG, and IgA antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: persistence of serum antibodies during disease. J Clin Microbiol (1979) 1.92
Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J (1999) 1.92
Cytosolic free calcium elevation mediates the phagosome-lysosome fusion during phagocytosis in human neutrophils. J Cell Biol (1990) 1.85
YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Mol Microbiol (1997) 1.74
Bursal and postbursal stem cells in chicken. Functional characteristics. Eur J Immunol (1973) 1.74
Serological diagnosis of salmonella infections by enzyme immunoassay. Lancet (1989) 1.72
YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Mol Microbiol (1996) 1.71
Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis (1987) 1.63
HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.61
Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes. Immunology (1982) 1.58
A solid-phase radioimmunoassay for IgG and IgM antibodies against measles virus. J Gen Virol (1977) 1.56
Influence of adhesins on the interaction of Escherichia coli with human phagocytes. Infect Immun (1984) 1.54
Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol (2000) 1.53
Prolonged arthritis associated with sindbis-related (Pogosta) virus infection. Rheumatology (Oxford) (2000) 1.52
The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand J Immunol (1991) 1.51
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology (1995) 1.49
Synovial T lymphocyte recognition of organisms that trigger reactive arthritis. Clin Exp Immunol (1989) 1.49
Yersinia enterocolitica mesenteric adenitis in a thalassaemic adolescent. Conservative management. Eur J Pediatr (1992) 1.49
Serologic evidence of Yersinia infection in patients with anterior uveitis. Arch Ophthalmol (1990) 1.48
Factors predicting interferon treatment response in patients with chronic hepatitis c: late viral clearance does not preclude a sustained response. Am J Gastroenterol (2001) 1.46
Bacterial virulence versus host resistance in the urinary tracts of mice. Infect Immun (1987) 1.45
Liability to hydrophobic and charge interaction of smooth Salmonella typhimurium 395 MS sensitized with anti-MS immunoglobulin G and complement. Infect Immun (1977) 1.45
Vibrio cholerae hemagglutinin/protease (HA/protease) causes morphological changes in cultured epithelial cells and perturbs their paracellular barrier function. Microb Pathog (1996) 1.42
Characterization of mutants of Salmonella typhimurium by counter-current distribution in an aqueous two-polymer phase system. Infect Immun (1973) 1.42
Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies. J Clin Microbiol (1993) 1.42
Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol (1994) 1.41
Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens. Infect Immun (1977) 1.40
Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases. Gastroenterology (1994) 1.37
Virulence-plasmid is associated with the inhibition of opsonization in Yersinia enterocolitica and Yersinia pseudotuberculosis. Clin Exp Immunol (1987) 1.36
Surface charge and hydrophobicity of Salmonella, E. coli, Gonococci in relation to their tendency to associate with animal cells. Scand J Infect Dis Suppl (1980) 1.35
IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis. Ann Rheum Dis (1986) 1.35
Radioimmunoassay of class-specific antibodies (RIACA): chicken antibodies to bovine serum albumin. Immunochemistry (1975) 1.33
Measurement of immunoglobulin M, immunoglobulin G, and immunoglobulin A antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: comparison of lipopolysaccharide and whole bacterium as antigen. J Clin Microbiol (1981) 1.31
Complete restoration of bursa-dependent immune system after transplantation of semiallogeneic stem cells into immunodeficient chicks. J Exp Med (1974) 1.29
Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients. Ann Rheum Dis (1987) 1.29
No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum (1999) 1.28
Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease? Gastroenterology (1999) 1.27
Surface-charge characteristics of smooth and rough Salmonella typhimurium bacteria determined by aqueous two-phase partitioning and free zones electrophoresis. Acta Pathol Microbiol Scand B (1977) 1.26
Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol (2005) 1.26
Reduction of phagocytosis, surface hydrophobicity and charge of Salmonella typhimurium 395 MR10 by reaction with secretory IgA (SIgA). Immunology (1979) 1.25
Yersinia pseudotuberculosis-induced calcium signaling in neutrophils is blocked by the virulence effector YopH. Infect Immun (1999) 1.25
Uptake of environmental antigens by the bursa of Fabricius. Nature (1975) 1.23
Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis. Ann Rheum Dis (1987) 1.22
Clinical manifestations of Yersinia pseudotuberculosis infection in children. Eur J Clin Microbiol Infect Dis (1989) 1.22
NSP4 enterotoxin of rotavirus induces paracellular leakage in polarized epithelial cells. J Virol (2001) 1.22
Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora. Chemotherapy (1976) 1.20
Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol (1998) 1.20
Ontogeny of bursal function in chicken. 3. Immunocompletent cell for humoral immunity. J Exp Med (1972) 1.20
Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. Gut (1991) 1.19
Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol (1994) 1.19
Pattern of formylmethionyl-leucyl-phenylalanine-induced luminol- and lucigenin-dependent chemiluminescence in human neutrophils. Infect Immun (1985) 1.19
Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum (1992) 1.19
Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis. Ann Rheum Dis (1991) 1.19
HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells. Eur J Immunol (1997) 1.18
Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis. Arthritis Rheum (1999) 1.17
Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis (2001) 1.16
Immunoblot analysis of human IgM, IgG and IgA responses to plasmid-encoded antigens of Yersinia enterocolitica serovar O3. J Med Microbiol (1987) 1.14
Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease. Acta Chir Scand (1983) 1.14
Hydrophobic interaction--a mechanism of bacterial binding. Scand J Infect Dis Suppl (1982) 1.14
Solid-phase radioimmunoassay of herpes simplex virus IgG and IgM antibodies. J Immunol Methods (1977) 1.13
Liver cell uptake and degradation of soluble immunoglobulin G immune complexes in vivo and in vitro in rats. Hepatology (1996) 1.13
Overproduction of outer membrane protein suppresses envA-induced hyperpermeability. J Bacteriol (1980) 1.13
Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol (1992) 1.11